Cinnamon polysaccharides (CP) administered to aging mice restructured gut microbiota composition, specifically enriching the commensal bacterium Alloprevotella rava. This microbial shift elevated serum and mammary tissue choline levels by upregulating host choline transporters and phosphatidylcholine biosynthetic enzymes, while simultaneously suppressing microbial choline-TMA lyase genes (cutA and cutC) that divert choline away from the host. Acetate—not succinate—emerged as the key bacterial metabolite mediating these effects, driving improved mitochondrial function and reduced cellular senescence markers in mammary tissue. Maternal supplementation additionally supported offspring brain development.
This work adds meaningful mechanistic specificity to the expanding field of microbiota-nutrient crosstalk. Choline is chronically underconsumed by most adults, and aging compounds this deficit by disrupting its metabolism—a double liability for mitochondrial integrity and phospholipid membrane maintenance. The identification of acetate as the operative effector, rather than other short-chain fatty acids, narrows the mechanistic target considerably and is a genuinely novel contribution.
That said, this is entirely mouse-model research, and translating microbiota-reshaping strategies from rodents to humans carries a historically poor track record. A. rava is not a commercially available probiotic, and whether CP supplementation reliably enriches it in human gut ecosystems—which are far more compositionally variable—remains unknown. The mammary-specific aging focus also limits generalizability. Incremental-to-confirmatory for the microbiota-choline-aging axis, but the acetate-mechanistic precision elevates its scientific value.
